Daraxonrasib/Rasonque Information

JuJu’s tips for skin care and prevention of other side effects while taking Daraxonrasib.

I started the Daraxonrasib RMC 304 adjuvant trial in August 2026. It’s a two-year trial to assess the success of Daraxonrasib in preventing pancreatic cancer recurrence in adjuvent patients who have undergone resection (Whipple surgery) and chemotherapy.

Trail participation is an extremely personal choice. It’s another hard thing, and nothing is guaranteed, so I deeply respect the opinions of my dear friends who choose not to participate in this trial.

I chose to participate in RMC 304 because I function best in a defensive mode. I didn’t want to feel like I was dropping my sword after chemotherapy. I was grateful to be randomized into the drug group. As of August, I take 300 mg of Daraxonrasib daily, and I have a whole slew of supplementary products to help with side effects.

Skin Care Routine

Face and body rashes are the most-common side effects of Daraxonrasib. Here’s how I care for my face daily. Note, this information should be helpful to anyone taking FDA-approved RASONQUE (the brand name for Daraxonrasib as of 2026).

These were the instructions given to me September 2026 by my oncology team at the start of my Daraxonrasib trial:

Here are a few of the important products you’ll need daily:

Sun Sensitivity on Daraxonrasib?

Sun sensitivity is supposed to be a common side effect, so I certainly take precautions. However, I’m getting lucky there. No sun sensitivity for me. (I had none during chemo, too.)